. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: J Vasc Interv Radiol. 2015 Jun 5;26(7):965–971. doi: 10.1016/j.jvir.2015.03.020

Table 4.

Summary of Univariate Logistic Regression Model Predicting the Probability of Having Liver Complications

Factor	OR	95% CI of OR		P Value
Gender (female vs male)	0.767	0.036	6.862	.824
Age (every 1-y increase)	0.990	0.913	1.066	.793
Type of tumor (HCC vs non-HCC)	1.412	0.315	7.661	.660
No. 70–150 μm DEB transarterial chemoembolization sessions (single vs multiple sessions)	1.029	0.248	4.393	.969
Other LRT before or after 70–150 μm DEB transarterial chemoembolization (yes vs no)	1.905	0.391	8.887	.413
Systemic therapy (yes vs no)	1.018	0.184	4.773	.983
Level of treatment (segmental vs subsegmental)	1.029	0.248	4.393	.969
ECOG class (0 vs 1 + 2)	1.574	0.364	6.734	.537
Overall lesion size before transarterial chemoembolization (cm; every 1-cm increase)	1.091	0.752	1.665	.656
Effective dose (per lesion; every 1-mg increase)	0.988	0.957	1.018	.412

Note–Absolute laboratory values and variations in percentage before and after DEB transarterial chemoembolization with LC/DC Bead^M1 were omitted because of the nonsignificant values encountered.

CI = confidence interval, DEB = drug-eluting bead, ECOG = Eastern Cooperative Oncology Group, HCC = hepatocellular carcinoma, LRT = local radiation therapy, OR = odds ratio.